Company Filing History:
Years Active: 2002
Title: An Overview of Inventor Lara Stoike-Steben
Introduction
Lara Stoike-Steben is a distinguished inventor based in Ann Arbor, Michigan, known for her contributions to the field of biomedical innovations. Her work primarily focuses on the detection and purification of fibrinogen fragments, which plays a significant role in various medical diagnostics and treatments.
Latest Patents
Lara holds one patent, titled "Cleaved fragments of fibrinogen." This groundbreaking invention provides novel α CX cleavage fragments of fibrinogen and methods for detecting and purifying these fragments. The diagnostic methods described in the patent are crucial for determining fibrinolytic states or atherogenesis in mammals. Additionally, the patent presents methods for treating diseases characterized by fibrinogen metabolism. It also includes monospecific antibodies that are specifically reactive with the α C domain of fibrinogen and specifies DNA and RNA molecules that encode the α C cleavage fragments of fibrinogen. Furthermore, the invention encompasses a vector and a host cell capable of expressing the α CX cleavage fragments of fibrinogen.
Career Highlights
Lara operates within the New York Blood Center, Inc. Her role there emphasizes the intersection of innovative research and practical applications in blood-related health solutions. With her expertise, Lara has made significant strides in enhancing understanding and treatment of conditions influenced by fibrinogen metabolism.
Collaborations
Throughout her career, Lara Stoike-Steben has collaborated with esteemed colleagues such as Gerd Grieninger and Dianne Applegate. These partnerships have fostered a conducive environment for innovation and the development of new diagnostic methods and treatments.
Conclusion
Lara Stoike-Steben's work epitomizes the impact of innovative thinking within the medical industry. Her pioneering patent on fibrinogen cleavage fragments not only advances scientific understanding but also promises improved diagnosis and treatment options for various conditions. Through her collaborations and continued research, Lara remains a vital contributor to the field of biomedical innovations.